Facebook  Twitter  Youtube  ISSUU  RSS  Email


Media Contacts

UK
Dominic Kavakeb
dominic.kavakeb@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police money laundering moneylaundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK “In Whose Interest?”, our report in July, called for a ban on Parliamentarians taking overseas trips that have been… https://t.co/f0Ayq4xqxu
TransparencyUK RT @rebecca_vincent: For those in the UK, please do ask your MP to sign this important cross-party motion renewing calls for #JusticeforDap
TransparencyUK “The changes lobbied for by law firms in 2010 which were eventually put into law by the government in 2011 made the… https://t.co/GTHu6oE8F4

Stay Informed

Sign up for updates on TI-UK's work & corruption news from around the globe.

Recent Blog Posts

Search Blog

Guest blogger Shalni Arora looks at corruption’s impact in the healthcare sector, and reflects on what it means for both the achievement of the new development goals as well as universal health coverage.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

While the ‘evergreening’ and ‘forced switching’ of pharmaceutical patents are legal practices, they act to reduce access to medicines for many and often those most vulnerable and so could be considered unethical or morally corrupt practices. Søren Holm, Professor of Bioethics at the University of Manchester, discusses the pharmaceutical patent game and its impacts.

Our response to today’s news that UK pharmaceuticals firm GlaxoSmithKline has been fined £297m for bribery by Chinese authorities. 

With a worth of US$6.5 trillion, the global healthcare industry is especially vulnerable to corruption. Although the problem is particularly acute in countries where corruption is endemic, no country is immune.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of